7Baggers

Applied Genetic Technologies Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20150630 20150930 20151231 20160331 20160630 20160930 20161231 20170331 20170630 20170930 20171231 20180331 20180630 20180930 20181231 20190331 20190630 20191231 20210630 20220630 -18.97-13.22-7.46-1.74.059.8115.5621.32Milllion

Applied Genetic Technologies Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2022-06-30 2021-06-30 2019-12-31 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 
  revenue325,000 500,000 2,453,000 406,000 21,318,000 5,934,000 14,034,000 5,416,000 3,603,000 4,852,000 10,315,000 8,345,000 8,388,000 10,933,000 11,806,000 12,113,000 11,997,000 12,189,000 11,062,000 713,000 284,000 652,000 705,000 124,000 232,000 515,000 258,000 377,000 116,000 190,000 259,000 
  cost of revenue
  gross profit325,000 500,000 2,453,000 406,000 21,318,000 5,934,000 14,034,000 5,416,000 3,603,000 4,852,000 10,315,000 8,345,000 8,388,000 10,933,000 11,806,000 12,113,000 11,997,000 12,189,000 11,062,000 713,000 284,000 652,000 705,000 124,000 232,000 515,000 258,000 377,000 116,000 190,000 259,000 
  operating expenses                               
  research and development13,574,000 10,003,000 8,375,000 8,332,000 7,203,000 7,583,000 10,065,000 8,826,000 7,353,000 7,726,000 8,276,000 8,301,000 6,303,000 6,041,000 5,571,000 6,756,000 7,868,000 7,203,000 17,037,000 4,553,000 4,104,000 3,438,000 4,433,000 2,702,000 2,128,000 2,230,000 1,443,000 1,233,000 744,000 617,000 539,000 
  sales, general and administrative                               
  total operating expenses18,049,000 14,286,000 11,383,000 11,846,000 10,313,000 10,605,000 13,278,000 12,195,000 11,299,000 11,094,000 11,982,000 11,148,000 9,224,000 8,781,000 8,417,000 9,626,000 10,230,000 9,319,000 20,275,000 8,743,000 6,675,000 5,354,000 6,114,000 4,549,000 3,492,000 3,420,000 2,224,000 1,664,000 1,067,000 986,000 819,000 
  operating income-17,723,000 -13,786,000 -8,930,000 -11,440,000 11,005,000 -4,671,000 756,000 -6,779,000 -7,696,000 -6,242,000 -1,667,000 -2,803,000 -836,000 2,152,000 3,389,000 2,487,000 1,767,000 2,870,000 -9,213,000 -8,030,000 -6,391,000 -4,702,000 -5,409,000 -4,425,000 -3,260,000 -2,905,000 -1,966,000 -1,287,000 -951,000 -796,000 -560,000 
  net income-18,972,000 -12,136,000 -8,623,000 -10,514,000 11,489,000 -4,181,000 1,200,000 -6,612,000 -8,101,000 -5,190,000 -1,397,000 -4,479,000 -821,000 2,081,000 3,625,000 2,728,000 1,969,000 3,045,000 -9,123,000 -7,961,000 -6,326,000 -4,650,000 -5,381,000 -4,521,000 -3,588,000 -735,000 -7,064,000 -1,428,000 -1,622,000 -1,336,000 -604,000 

We provide you with 20 years income statements for Applied Genetic Technologies stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Applied Genetic Technologies stock. Explore the full financial landscape of Applied Genetic Technologies stock with our expertly curated income statements.

The information provided in this report about Applied Genetic Technologies stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.